Finland
# |
Name |
Total Assets |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 1.59 B
|
Dec. 31, 2023 | USD 45.55 | -0.27% |
|
Finland |
|
2 |
USD 151.67 M
|
Dec. 31, 2023 | USD 26.42 | 0.60% |
|
Finland |
|
3 |
USD 101.47 M
|
Dec. 31, 2023 | USD 3.59 | 3.74% |
|
Finland |
|
4 |
USD 86.24 M
|
Dec. 31, 2023 | USD 1.33 | 4.66% |
|
Finland |
|
5 |
USD 32.10 M
|
Dec. 31, 2023 | USD 4.48 | 0.37% |
|
Finland |
|
6 |
USD 14.26 M
|
Dec. 31, 2023 | USD 3.51 | -13.37% |
|
Finland |
|
7 |
USD 10.91 M
|
Dec. 31, 2023 | USD 8.76 | -1.71% |
|
Finland |
The Pharmaceuticals company in Finland with the highest Total Assets is Orion Oyj (Helsinki Stock Exchange: ORNBV.HE) at USD 1.59 B.
The Pharmaceuticals company in Finland with the lowest Total Assets is Nexstim Plc (Helsinki Stock Exchange: NXTMH.HE) at USD 10.91 M.
The top 10 Pharmaceuticals companies in Finland by Total Assets are Orion Oyj, Revenio Group Oyj, Nordhealth AS, Nanoform Finland Oyj, Optomed Oyj, Biohit Oyj and Nexstim Plc.
The bottom 10 Pharmaceuticals companies in Finland by Total Assets are Nexstim Plc, Biohit Oyj, Optomed Oyj, Nanoform Finland Oyj, Nordhealth AS, Revenio Group Oyj and Orion Oyj.